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phingolipids (SLs) are plasma membrane constituents
in eukaryotic cells which play important roles in a
wide variety of cellular functions. However, little is
known about the mechanisms of their internalization from
 
the plasma membrane or subsequent intracellular targeting.
 
We have begun to study these issues in human skin ﬁbroblasts
using ﬂuorescent SL analogues. Using selective endocytic
inhibitors and dominant negative constructs of dynamin
and epidermal growth factor receptor pathway substrate
clone 15, we found that analogues of lactosylceramide and
globoside were internalized almost exclusively by a clathrin-
independent (“caveolar-like”) mechanism, whereas an
analogue of sphingomyelin was taken up approximately
equally by clathrin-dependent and -independent pathways.
S
 
We also showed that the Golgi targeting of SL analogues
internalized via the caveolar-like pathway was selectively
perturbed by elevated intracellular cholesterol, demonstrating
the existence of two discrete Golgi targeting pathways.
Studies using SL-binding toxins internalized via clathrin-
dependent or -independent mechanisms conﬁrmed that
endogenous SLs follow the same two pathways. These ﬁnd-
ings (a) provide a direct demonstration of differential SLs
sorting into early endosomes in living cells, (b) provide a
“vital marker” for endosomes derived from caveolar-like
 
endocytosis, and (c) identify two independent pathways
for lipid transport from the plasma membrane to the Golgi
apparatus in human skin ﬁbroblasts.
 
Introduction
 
Sphingolipids (SLs)* are synthesized in the endoplasmic
reticulum and Golgi apparatus of eukaryotic cells and are
subsequently transported to the plasma membrane (PM),
where they are highly enriched (Schwarzmann and Sand-
hoff, 1990; van Meer and Holthuis, 2000). Some PM SLs
may not be homogeneously distributed in the plane of the
membrane bilayer, but are thought to be concentrated,
along with cholesterol, in membrane microdomains (Edidin,
1997; Rietveld and Simons, 1998; Brown and London,
2000). In principle, SLs at the PM may be internalized by
one or more endocytic mechanisms, either as part of mem-
brane recycling or remodeling, or as a consequence of spe-
cific endocytic events induced by binding of ligands to PM
receptors. Once internalized from the PM, lipids can be
transported to other intracellular destinations (e.g., lyso-
somes or the Golgi complex); however, the specific pathways
for internalization and intracellular targeting of PM SLs are
not well characterized, primarily because of methodological
limitations in studying the transport of endogenous lipids
(see Pagano, 1990). Consequently, the movement of PM
lipids along the endocytic pathway has been examined by
using (a) labeled (fluorescent, biotinylated, spin labeled, or
radiolabeled “short chain”) lipid analogues (Pagano and
Sleight, 1985; Schwarzmann and Sandhoff, 1990; Hoekstra
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and Kok, 1992), or (b) labeled toxins which bind to certain
endogenous SLs and can be used to trace lipid distribution
and transport in cells (Sandvig and van Deurs, 1996; Jo-
hannes and Goud, 1998).
Using these methods, several fluorescent SL analogues and
SL-binding toxins have been shown to be endocytosed by
temperature- and energy-dependent processes (Koval and
Pagano, 1989, 1990; Schwarzmann and Sandhoff, 1990;
Hoekstra and Kok, 1992; Martin and Pagano, 1994). Recy-
cling of fluorescent sphingomyelin (SM) (Koval and Pagano,
1989, 1990; Mayor et al., 1993) and glucosylceramide
(GlcCer) (Kok et al., 1991, 1992) between intracellular
membranes and the PM has been studied extensively in a
number of cell types, including human skin fibroblasts,
CHO cells, and polarized cells. In addition to recycling, in-
ternalized lipids may be specifically targeted to other intra-
cellular compartments, such as late endosomes/lysosomes and
the Golgi apparatus, and evidence for endocytic sorting of
lipids between these compartments has been provided by
several groups (Kok et al., 1991; Mukherjee et al., 1999;
Puri et al., 1999). Evidence that some SLs are targeted to the
Golgi apparatus after endocytosis comes from the use of
biotinylated, fluorescent, or nondegradable SL analogues, or
the labeled B-subunits of cholera toxin (CtxB) or shiga toxin
(StxB) which bind to GM
 
1
 
 ganglioside and globoside, re-
spectively (Schwarzmann and Sandhoff, 1990; Schwarz-
mann et al., 1995; Chen et al., 1998; Puri et al., 1999;
Grimmer et al., 2000; Sandvig and van Deurs, 2000).
Figure 1. Internalization of fluorescent 
LacCer from the plasma membrane of 
human skin fibroblasts into very early 
endosomes. (a) Cells were incubated for 
30 min at 10 C with 2  M BODIPY-
LacCer, washed, and immediately 
observed (left) or warmed for 30 s at 
37 C and back exchanged (right) before 
observation under the fluorescence mi-
croscope at green wavelengths. (b) Cells 
were incubated for 30 min at 10 C with 
2  M BODIPY-LacCer, washed, warmed 
for 30 s at 37 C, back exchanged, and 
observed by confocal microscopy. Note 
the discrete punctate fluorescent struc-
tures which outlined the region of the 
nucleus (N). The right panel shows a 
specimen which was warmed for 30 s, 
but back exchanged for a shorter period 
of time than the left, so that the outline 
of the cell could also be seen. (c) Cells 
were transfected with GFP-tagged wild-
type (WT Dyn2ab) or mutant (Dyn2ab 
K44A) dynamin 2 constructs and subse-
quently pulse labeled with BODIPY-Lac-
Cer as in panel a. Transfected cells were 
identified by GFP-fluorescence; BODIPY-
lipids were observed at red wavelengths. 
No red fluorescence could be detected 
in transfected cells which were not 
treated with the fluorescent SLs. Virtu-
ally identical results to panels a–c were 
also obtained using BODIPY-SM (data 
not shown). Bars, 10  m. 
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The relative importance of specific mechanisms for the
endocytosis and intracellular targeting of PM SLs are not
known. Studies using StxB bound to the cell surface show
that this lipid–toxin complex is internalized via clathrin-
dependent endocytosis (Johannes and Goud, 1998). In addi-
tion, a fluorescent analogue of SM partially colocalizes with
endocytosed transferrin receptor within seconds of internal-
ization from the PM, suggesting that at least a portion of the
SM analogue is endocytosed via the clathrin pathway (Chen
et al., 1997). A second potential mechanism for endocytosis
of SLs is internalization via caveolae. Endocytosis through
caveolae has been best characterized as a mechanism for the
entry of small molecules such as folic acid; however, CtxB
bound to GM
 
1
 
 ganglioside, endothelin and growth hor-
mone receptors, antibody–cross-linked alkaline phosphatase,
SV-40 virus, and bacteria have all been reported to be inter-
nalized via caveolae or “caveolar-like” processes (Parton,
1994; Orlandi and Fishman, 1998; Chen and Norkin,
1999; Lobie et al., 1999; Okamoto et al., 2000; Shin et al.,
2000; Pelkmans et al., 2001). Finally, in addition to the
clathrin and caveolar endocytic mechanisms, caveolar-like
endocytosis is exhibited by certain cell types that lack ca-
veolin-1, and some reports suggest the existence of addi-
tional nonclathrin, noncaveolar endocytic processes in some
cells (Orlandi and Fishman, 1998; Sandvig and van Deurs,
2000).
In the current study, we examine the mechanism of en-
docytosis of several different SL analogues from the PM of
human skin fibroblasts and provide evidence that two gly-
cosphingolipid (GSL) analogues were selectively internalized
via a clathrin-independent pathway, whereas another SL,
SM, was internalized by both clathrin-dependent and -inde-
pendent mechanisms. Furthermore, we show that although
both internalization pathways led to Golgi targeting of SLs
in normal cells, the initial mode of internalization was a ma-
jor factor in determining the subsequent targeting of the SLs
to late endosomes/lysosomes versus the Golgi apparatus in
SL storage disease (SLSD) fibroblasts. These findings were
confirmed using SL binding toxins which monitor the traf-
ficking of endogenous SLs at the PM, demonstrating that
our results were not limited to fluorescent SL analogues.
 
Results
 
Initial pathway of SL internalization in normal human 
skin fibroblasts
 
Our studies used fluorescent analogues of SM, lactosylcer-
amide (LacCer), and globoside containing a boron dipyr-
romethenedifluoride (BODIPY)-labeled fatty acid (Kang
and Haugland, 1989; Pagano et al., 1991). The fluorescence
emission of these analogues changes from green (G) to red
(R) wavelengths with increasing concentration in mem-
branes due to excimer formation, and measurements of the
“R/G ratio” by quantitative fluorescence microscopy can
give information about the concentration of an analogue
within an intracellular organelle in living cells (Pagano et al.,
1991; Chen et al., 1997). When human skin fibroblasts
were incubated with BODIPY-LacCer or -SM for 30 min at
10
 
 
 
C, washed, and observed by conventional or confocal
fluorescence microscopy, only PM labeling was seen and the
fluorescence appeared to be uniformly distributed (LacCer,
Fig. 1 a, left; SM, data not shown). Using R/G ratios of fluo-
rescence images, as well as lipid extraction and analysis, we
found that a 30 min pulse at 10
 
 
 
C with 2 
 
 
 
M BODIPY-
LacCer or 1 
 
 
 
M BODIPY-SM resulted in “equal loading”
of the SL analogues in the PM (2.92 
 
 
 
 0.11 vs. 2.99 
 
 
 
 0.29
nmol/mg protein, respectively) and an R/G ratio of 1.0.
When the labeled cells were then incubated for 30 s at
37
 
 
 
C to allow internalization of the fluorescent analogues to
occur and then back exchanged at 10
 
 
 
C in the presence of
metabolic inhibitors to block further endocytosis and to re-
move any fluorescent SL remaining at the PM (Chen et al.,
1997), numerous fluorescent punctate structures were ob-
served which were widely scattered throughout the cyto-
plasm, as shown in Fig. 1 a (right) for the LacCer analogue.
Confocal microscopy demonstrated that most of the fluores-
cent lipid which was resistant to back exchange was intracel-
 
Table I. 
 
Inhibition of sphingolipid endocytosis by biochemical treatments and dominant negative constructs
Clathrin-independent internalization Clathrin-dependent internalization
Clathrin-dependent
and -independent
Nystatin
 
1
 
Genistein
 
1
 
m
 
 
 
-CD
 
1
 
Chlorpromazine
 
1
 
K
 
 
 
 depletion
 
1
 
Eps15 mutant
 
2
 
Dynamin mutant
 
2
 
%% % % % % %
 
Rh-CTXB 74.9 
 
 
 
 7.53
 
3
 
80.8 
 
 
 
 2.8 81.4 
 
 
 
 16.9 0.8 
 
 
 
 0.1 2.6 
 
 
 
 1.6 – –
DiI-LDL 2.6 
 
 
 
 1.4 3.3 
 
 
 
 2.3 1.8 
 
 
 
 0.4 78.3 
 
 
 
 18.2 76.0 
 
 
 
 2.3 – –
BODIPY-LacCer 73.9 
 
 
 
 5.0 82.0 
 
 
 
 4.5 81.0 
 
 
 
 14.9 0.7 
 
 
 
 0.1 7.0 
 
 
 
 0.0 2.6 
 
 
 
 0.2 94.3 
 
 
 
 4.0
BODIPY-Globoside – 81.6 
 
 
 
 5.5 83.8 
 
 
 
 14.9 0.9 
 
 
 
 0.2 0.0 
 
 
 
 0.0 – –
BODIPY-SM 48.8 
 
 
 
 3.1 48.8 
 
 
 
 4.3 44.9 
 
 
 
 10.7 50.1 
 
 
 
 13.8 51.2 
 
 
 
 3.6 49.0 
 
 
 
 13.2 95.2 
 
 
 
 2.4
 
1
 
Cells were pretreated with or without the indicated inhibitor (see Materials and methods) and subsequently incubated at 10
 
 
 
C with DiI-LDL, Rh-CtxB, or
BODIPY-SL. The samples were then warmed for 5 min at 37
 
 
 
C to allow endocytosis to occur and then back exchanged to remove fluorescent lipid remain-
ing at the PM. Samples were then observed under the fluorescence microscope and the percentage of inhibition of internalization of the marker or lipid an-
alog was determined by image analysis of the fluorescently labeled cells. Image analysis results were validated for BODIPY-LacCer and -SM by lipid extrac-
tion and analysis (data not shown).
 
2
 
Cells were transfected with plasmids expressing GFP-tagged mutant or wild-type constructs of Dyn2ab or Eps15 (See Materials and methods), incubated
with BODIPY-LacCer or -SM as in footnote 1, and observed under the fluorescence microscope. Transfected cells were identified by GFP fluorescence. BO-
DIPY-SLs were observed at red wavelengths. No red fluorescence could be detected in transfected cells which were not treated with fluorescent SLs.
 
3
 
Percentage inhibition is relative to internalization in untreated control cells for drug treatments, or relative to internalization using wild-type constructs for
Eps15 or dynamin. Values are mean 
 
 
 
 SD of at least 10 cells in each of three independent experiments. 
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lular and not continuous with the cell surface. This was
clearly shown by the presence of discrete punctate fluores-
cent structures outlining the region of the nucleus (N) in op-
tical sections through the center of the cell after 30 s of inter-
nalization (Fig. 1 b, left). An image is also presented of a cell
after incomplete back exchange so that the PM can be
readily discerned in relation to endocytic vesicles (Fig. 1 b,
right). When identical experiments were carried out using
human skin fibroblasts expressing a dominant negative mu-
tant of dynamin (van der Bliek et al., 1993), no internaliza-
tion of BODIPY-LacCer into punctate structures could be
detected (Fig. 1 c). In contrast, the punctate structures visu-
alized after 30 s at 37
 
 
 
C appeared identical to those shown
in Fig. 1 a when cells were transfected with a wild-type dy-
namin (Fig. 1 c). Expression of the dominant negative dy-
namin construct also completely blocked the internalization
of BODIPY-SM (data not shown). For convenience, we
hereafter refer to the punctate structures derived from fluo-
rescent SL analogue internalization as “endocytic vesicles” or
“endosomes,” but do not mean to infer that these vesicles
represent a discrete endosomal compartment.
We next studied the fate of BODIPY-LacCer and -SM
present in “30 s endosomes” after various periods of further
chase at 37
 
 
 
C (Fig. 2). There were no obvious differences in
the number or distribution of endosomes formed from Lac-
Cer versus SM after the initial 30 s of internalization. How-
ever, at this time point virtually all of the endosomes ap-
peared green in color when LacCer was used, whereas in the
case of SM, numerous red/orange endosomes (indicative of
high BODIPY-SM concentrations) as well as green endo-
Figure 2. Internalization of fluorescent 
SL analogues from the plasma mem-
brane of human skin fibroblasts into 
very early endosomes. (a) Cells were in-
cubated with BODIPY-LacCer or -SM at 
10 C using SL concentrations that re-
sulted in incorporation of equal amounts 
of the analogues in the PM. The cells 
were then washed, warmed for 30 s at 
37 C, back exchanged, chased for 0, 10, 
or 60 s at 37 C in the absence of inhibi-
tors, and observed under the microscope 
at green   red wavelengths. (b) Cells 
were pulse-labeled as in panel a and 
the R/G ratio (a measure of the molar 
density of the SL analogue) of  500 
endosomes in 3–5 cells was quantified 
for each data point. Values are mean   
SD. Bar, 10  m. 
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somes were seen (Fig. 2 a, 30”/0”). After further incubation
at 37
 
 
 
C in the absence of metabolic inhibitors, there was no
obvious qualitative change in the appearance of the SM-con-
taining endosomes during 10–60 s of chase (Fig. 2 a). How-
ever, for LacCer, many red/orange endosomes were observed
at 10 s, but at later times of chase all endosomes became
green in color (Fig. 2 a). Analogous experiments were carried
out using BODIPY-globoside, which behaved similarly to
the LacCer analogue (data not shown). The changes in R/G
ratios of SM- and LacCer-containing endosomes over time
are also shown quantitatively (Fig. 2 b). These results show
that LacCer, but not SM, was transiently concentrated in
early endosomes and suggested that the BODIPY-LacCer
and -SM analogues might be internalized by different mech-
anisms and/or sorted differently after internalization.
To further test this hypothesis, we used a series of path-
way-specific inhibitors of endocytosis to learn whether there
was a differential effect on the internalization of the LacCer
and SM analogues from the PM (Table I). We first evalu-
ated various concentrations of these inhibitors to maximize
their specificity and eliminate toxic side effects. Under opti-
mized conditions, chlorpromazine and K
 
 
 
 depletion inhib-
 
ited the internalization of fluorescent LDL (DiI-LDL), a
marker for the clathrin pathway, by 
 
 
 
75%, but had no ef-
fect on the uptake of rhodamine-labeled CtxB (Rh-CtxB), a
marker for caveolar and caveolar-like internalization (Par-
ton, 1994; Orlandi and Fishman, 1998). Conversely, treat-
ment with methyl-
 
 
 
-cyclodextrin (m
 
 
 
-CD), nystatin, or
genistein significantly inhibited (
 
 
 
75–81%) Rh-CtxB inter-
nalization, but had no effect on DiI-LDL uptake. Internal-
ization of BODIPY-LacCer (at 5 min) was almost com-
pletely inhibited by pretreatment of cells with m
 
 
 
-CD,
nystatin, or genistein, but was unaffected by chlorpromazine
or K
 
 
 
 depletion (Table I). BODIPY-globoside internaliza-
tion was similarly inhibited by drugs which affect the caveo-
lar-like pathway. In contrast, internalization of BODIPY-
SM was inhibited 45–50% using each inhibitor, suggesting
that BODIPY-SM is internalized by both clathrin-depen-
dent and clathrin-independent mechanisms.
To complement the experiments using inhibitors, we next
expressed recombinant proteins reported to inhibit specific
endocytic mechanisms and determined their effects on the
internalization of BODIPY-LacCer and -SM. For these
studies, green fluorescent protein (GFP)-tagged constructs
Figure 3. Role of dynamin and Eps15 
in the internalization of BODIPY-
LacCer and -SM from the PM. Human 
skin fibroblasts were transfected with 
plasmids expressing GFP-tagged mutant 
or wild-type (WT) constructs of (a) 
Dyn2ab or (b) Eps15. Cells were subse-
quently incubated for 30 min at 10 C 
with 5  M BODIPY-LacCer or -SM, 
washed, warmed for 5 min at 37 C, back 
exchanged, and observed under the 
fluorescence microscope. GFP and 
BODIPY-SLs were visualized as in Fig. 1. 
Bars, 10  m. 
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were used so that transfected fibroblasts could be readily
identified by green fluorescence, whereas internalization of
BODIPY-lipids was visualized in the red region of the spec-
trum. First, human skin fibroblasts were transfected with
constructs of dynamin, a protein previously shown to be in-
volved in endocytosis from both clathrin-coated pits and ca-
veolae (Herskovits et al., 1993; van der Bliek et al., 1993;
Henley et al., 1998; Oh et al., 1998). No internalization of
BODIPY-LacCer or -SM was seen after 5 min at 37
 
 
 
C in
cells expressing a dynamin K44A mutant, whereas SL inter-
nalization in cells transfected with the wild-type dynamin
construct was indistinguishable from that in nontransfected
cells (Fig. 3 a; Table I). When cells were transfected with
a dominant negative EGFR pathway substrate clone 15
(Eps15) mutant which inhibits clathrin-mediated endocyto-
sis (Benmerah et al., 1999), LacCer internalization was unaf-
fected, whereas SM internalization was significantly inhib-
ited (Fig. 3 b; Table I), consistent with our inhibitor results
showing partial inhibition of SM internalization by chlor-
promazine and K
 
 
 
 depletion. Lipid internalization in cells
transfected with wild-type Eps15 was indistinguishable from
nontransfected cells (Fig. 3 b).
We next carried out colocalization studies using the fluo-
rescent SL analogues and DiI-LDL or Rh-CtxB as endocytic
markers. Preliminary studies in which cells were doubly la-
beled with fluorescent LDL and CtxB at 10
 
 
 
C and sub-
sequently incubated for 5 min at 37
 
 
 
C showed almost
no colocalization of these markers (data not shown), consis-
tent with their initial internalization by different pathways
 
(clathrin-dependent versus clathrin-independent). Next, we
examined the overlap of Rh-CtxB and DiI-LDL with caveo-
lin-1–GFP, shown previously to behave the same as endoge-
nous caveolin-1 (Pelkmans et al., 2001). We found that Rh-
CtxB (but not DiI-LDL) extensively colocalized with caveo-
lin-1–GFP after 5 min at 37
 
 
 
C (Fig. 4). This result suggests
that in human skin fibroblasts, CtxB is a valid marker for
caveolae as defined by the presence of caveolin-1–GFP.
Finally, there was extensive colocalization (
 
 
 
80%) of
BODIPY-LacCer with Rh-CtxB but not with DiI-LDL,
whereas BODIPY-SM showed partial overlap with both
markers (Fig. 5).
Together, the results in Figs. 1–5 demonstrate that (a) all
the fluorescent SL analogues were internalized from the PM
by a vesicle-mediated process, (b) the LacCer and globoside
analogues were endocytosed almost exclusively by a clathrin-
independent (caveolar-like) mechanism, and (c) the SM ana-
logue was internalized approximately equally by both clath-
rin-dependent and -independent mechanisms.
 
Internalization and subsequent targeting of SL 
analogues in storage disease fibroblasts and in normal 
cells overloaded with cholesterol
 
BODIPY-LacCer is internalized from the PM and trans-
ported predominantly to the Golgi complex of normal cells,
whereas in numerous SLSD cell types, the LacCer analogue
accumulates in punctate cytoplasmic vesicles which partially
colocalize with fluorescent dextran and lysotracker dyes as a
Figure 4. Colocalization of Rh-CtxB 
and DiI-LDL with caveolin-1–GFP in 
human skin fibroblasts. Cells were trans-
fected with a plasmid expressing caveolin-
1–GFP (COOH-terminal; see Materials 
and methods) and subsequently incu-
bated with 0.2  M Rh-CtxB or 0.5  g/ml 
DiI-LDL for 30 min at 10 C, washed, and 
warmed for 5 min at 37 C. The samples 
were then observed by confocal micros-
copy. Note the extensive colocalization 
of Rh-CtxB (but not DiI-LDL) with 
caveolin-1–GFP. No crossover between 
red and green fluorescence channels 
could be detected in control cells labeled 
with marker alone (i.e., Rh-CtxB or DiI-
LDL) or in caveolin-1-GFP–labeled cells 
containing no marker. 
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result of elevated intracellular cholesterol (Chen et al., 1998,
1999; Puri et al., 1999; unpublished data). Therefore, it was
of interest to learn whether the initial internalization mecha-
nism for LacCer was altered in SLSD cells. We found that
pretreatment of SLSD cells with m
 
 
 
-CD followed by pulse-
labeling with the LacCer analogue eliminated nearly all intra-
cellular labeling, whereas chlorpromazine had no effect using
Niemann Pick Type C (NP-C) (Fig. 6 a), Niemann Pick
Type A, GM
 
1
 
- or GM
 
2
 
-gangliodosis cells (data not shown).
Transfection with dominant negative Eps15 also had no ef-
fect on LacCer internalization or targeting in these cell types
(data not shown). Thus, BODIPY-LacCer was internalized
via a chlorpromazine- and Eps15-insensitive mechanism in
SLSD cells as well as in normal cells, even though Golgi tar-
geting is disrupted in these cells. Furthermore, BODIPY-glo-
boside was also targeted to endosomes/lysosomes in SLSD
cells and this internalization was similarly m
 
 
 
-CD-sensitive
and chlorpromazine-insensitive (data not shown).
In contrast, the SM analogue was targeted to both the
Golgi complex and to punctate structures in the cytoplasm of
SLSD cells (e.g., NP-C) (Fig. 6 a, BODIPY-SM and Un-
treated), whereas in normal cells it was transported primarily
to the Golgi apparatus (Fig. 6 b, Control). Importantly, m
 
 -
CD treatment selectively blocked targeting of BODIPY-SM
to the endosomes/lysosomes, whereas chlorpromazine treat-
ment (Fig. 6 a) and mutant Eps15 (data not shown) blocked
transport to the Golgi. In control experiments, we used BO-
DIPY-ceramide as a vital stain for the Golgi apparatus
(Lipsky and Pagano, 1985; Pagano et al., 1991) and showed
that the morphology of this organelle was not significantly af-
fected in chlorpromazine-treated NP-C cells (Fig. 6 a, inset).
Thus, the absence of SM targeting to the Golgi complex with
chlorpromazine was not due to disruption of this organelle.
Identical results to those in Fig. 6 a were also obtained using
GM2 gangliosidosis and Niemann pick type A (NP-A) fibro-
blasts; other SLSD cell types have not been tested.
In parallel experiments, we also studied the trafficking of
BODIPY-SM and -LacCer in normal fibroblasts after over-
loading the cells with cholesterol (Fig. 6 b). In control fibro-
blasts with normal levels of cholesterol, both the SM and Lac-
Cer analogues were targeted primarily to the Golgi apparatus,
although some punctate cytoplasmic fluorescence was also
seen. In contrast, when cells were grown under conditions
which elevated cellular cholesterol (Puri et al., 1999), Golgi
Figure 5. Colocalization of endo-
somes labeled by fluorescent LacCer or 
SM with endocytic markers. Cells were 
incubated with 0.5  M (a) BODIPY-
LacCer or (b) BODIPY-SM, and 0.2  M 
Rh-CtxB or 0.5  g/ml DiI-LDL for 30 
min at 10 C, washed, warmed for 30 s at 
37 C, back exchanged, and chased for 
30 s at 37 C in the absence of inhibitors 
before fluorescence microscopy. 
(a) Note the extensive colocalization of 
BODIPY-LacCer and Rh-CtxB, visible as 
yellow orange fluorescence, whereas 
little colocalization of BODIPY-LacCer 
was seen with DiI-LDL. (b) Note the par-
tial overlap of BODIPY-SM with both 
Rh-CtxB and DiI-LDL. Quantitative mea-
surements of the overlap of BODIPY-
LacCer or BODIPY-SM with Rh-CtxB 
and DiI-LDL, determined by image 
processing, were: LacCer/Rh-CtxB, 
83.1   2.3%; LacCer/DiI-LDL, 5.7   
1.1%; SM/Rh-CtxB, 40.6   3.2%; SM/
DiI-LDL, 54.1   2.5%. Values are the 
mean   SD for  200 endosomes in 3–5 
cells. Bars, 10  m.542 The Journal of Cell Biology | Volume 154, 2001
targeting of LacCer was eliminated and almost all the lipid
was targeted to punctate cytoplasmic structures. In the case of
SM, overloading with cholesterol did not eliminate Golgi tar-
geting, but the punctate cytoplasmic staining was much more
prominent than in control cells (Fig. 6 b, XS-Chol). Chlor-
promazine had no effect on LacCer targeting in cholesterol-
overloaded cells, whereas for the SM analogue, punctate cyto-
plasmic labeling without any obvious Golgi fluorescence was
now observed (Fig. 6 b, XS-Chol   chlorpromazine). In con-
trol experiments with normal cells, chlorpromazine did not
affect the Golgi targeting of BODIPY-SM or -LacCer inter-
nalized through the clathrin-independent pathway (data not
shown). These results show that SL uptake through the clath-
rin pathway gave rise to Golgi labeling in all cell models
tested, whereas SLs which enter by the clathrin-independent
route are subject to cholesterol-modulated intracellular tar-
geting in both normal and SLSD fibroblasts.
Finally, we studied the internalization and targeting of en-
dogenous PM SLs in control and SLSD fibroblasts using flu-
orescently labeled SL-binding toxins. For these experiments
we used CtxB, which binds to GM1 ganglioside and is inter-
nalized via caveolae or a caveolar-like mechanism (Orlandi
and Fishman, 1998), and StxB, which binds globosides and
is internalized by clathrin-mediated endocytosis (Sandvig
and van Deurs, 1994; Johannes and Goud, 1998). As shown
in Fig. 7, CtxB was targeted to the Golgi apparatus of nor-
mal cells, but to punctate structures in GM1 gangliosidosis
fibroblasts. Importantly, we found that cholesterol depletion
of GM1 gangliosidosis fibroblasts restored the targeting of
CtxB to the Golgi complex of these cells (Fig. 7), similar to
the effect of cholesterol depletion on BODIPY-LacCer tar-
geting in SLSD cells (Puri et al., 1999). In contrast, StxB
was transported to the Golgi complex of both normal and
GM1 gangliosidosis cells regardless of the level of cellular
cholesterol. Similar results were obtained using these toxins
in GM2 gangliosidosis, NP-A, and NP-C fibroblasts (data
not shown).
Discussion
In this study we used a series of fluorescent SL analogues, as
well as SL binding toxins, to study the internalization and
subsequent intracellular targeting of SLs from the PM
of human skin fibroblasts. We found that two different
GSL analogues, LacCer and globoside, were internalized
nearly exclusively through a clathrin-independent, caveolar-
Figure 6. Intracellular targeting of en-
docytosed fluorescent SL analogues 
depends on the initial mechanism of in-
ternalization. (a) Effects of pathway-
specific inhibitors on BODIPY-LacCer 
and -SM targeting in SLSD cells. NP-C fi-
broblasts were pretreated (or Untreated) 
with chlorpromazine or m -CD to block 
clathrin-dependent or -independent en-
docytosis, respectively, and then labeled 
(pulse for 30 min at 10 C; chase for 30 
min at 37 C) with the indicated BO-
DIPY-SL. Note that both the endosomes/
lysosomes and the Golgi complex (G) 
were labeled by the SM analogue and 
that targeting to these compartments was 
differentially affected by chlorpromazine 
and m -CD. Inset shows that the Golgi 
morphology of a different cell, visualized 
using BODIPY-ceramide, was unaffected 
by chlorpromazine treatment. (b) Effect 
of excess LDL-cholesterol (XS-Chol) and 
chlorpromazine treatment on the inter-
nalization of BODIPY-SM versus -LacCer 
in normal human skin fibroblasts. Cells 
with normal (control) or excess choles-
terol were pulse-labeled as above with 
BODIPY-SM or -LacCer. Note the absence 
of Golgi complex labeling in the sample 
treated with the SM analogue with chlor-
promazine. Bars, 10  m.Endocytosis and targeting of sphingolipids | Puri et al. 543
like pathway, whereas another SL, SM, was internalized ap-
proximately equally by both clathrin-dependent and -indepen-
dent mechanisms. These findings are the first direct demon-
stration of differential SL sorting into early endosomes in
living cells and provide cell biologists with a “vital marker”
for endocytic vesicles derived from caveolar-like internaliza-
tion. A second important finding in the current study is that
the endocytic mechanism for SL internalization determines
the subsequent pathway by which the lipids are targeted
to the Golgi complex. Although it is already known that dif-
ferent membrane proteins can reach the Golgi complex by
different routes, we believe this is the first demonstration of
multiple Golgi targeting pathways for lipids. Finally, we
show that elevated cellular cholesterol specifically perturbs
Golgi targeting of SLs internalized through the clathrin-
independent pathway, but has no effect on the targeting of
lipids which enter via the coated pit pathway. This result dem-
onstrates that cholesterol plays an important role in the in-
tracellular targeting of lipids after their entry via the clath-
rin-independent route. Importantly, several of the results in
the present study were confirmed using fluorescently labeled
toxins to study the internalization and intracellular targeting
of endogenous SLs from the PM. These experiments provide
strong evidence that endogenous SLs internalized via the
clathrin-dependent or -independent pathways follow the
same intracellular transport pathways as the fluorescent SLs
in both normal and SLSD fibroblasts.
LacCer and globoside, but not SM, are 
internalized almost exclusively by a 
clathrin-independent mechanism
Our results show that BODIPY-LacCer and -globoside were
internalized from the PM of human skin fibroblasts exclu-
sively by a clathrin-independent mechanism. Several lines of
evidence strongly suggest that this clathrin-independent
mechanism involved internalization through caveolae. First,
we showed that inhibitors of caveolar-like endocytosis (e.g.,
of CtxB) completely blocked internalization of LacCer,
whereas inhibitors of clathrin-dependent endocytosis had no
significant effect on LacCer internalization. In contrast, up-
take of SM was partially inhibited by both classes of inhibi-
tors. To rule out nonspecific effects of the drug treatments,
we demonstrated similar results using multiple inhibitors,
which inhibit endocytosis by different mechanisms. Second,
we demonstrated that the internalization of LacCer and SM
were both inhibited by expression of a dominant negative
dynamin mutant. Inhibition of internalization of both lipids
is consistent with our interpretation of the endocytic mecha-
nisms involved in SL uptake, since dynamin is reported to
Figure 7. Internalization of fluorescent CtxB and StxB in normal and GM1 gangliosidosis fibroblasts. Cells were incubated with FITC-
labeled CtxB or StxB for 30 min at 10 C, washed, and further incubated for 2–3 h (CtxB) or 1 h (StxB) at 37 C. Note that StxB was targeted to 
the Golgi (G) in both cell types, whereas CtxB labeled the Golgi of normal cells and punctate cytoplasmic structures in GM1 gangliosidosis 
cells. Furthermore, cholesterol depletion of GM1 gangliosidosis cells induced CtxB targeting to the Golgi complex (inset shows the Golgi 
region from another cell in the same experiment). Bar, 10  m.544 The Journal of Cell Biology | Volume 154, 2001
be essential for both clathrin-dependent and caveolar up-
take. Expression of an Eps15 dominant negative mutant af-
fected only the internalization of SM, consistent with our re-
sults showing partial inhibition of SM, but not LacCer,
uptake by inhibitors of the clathrin pathway.
To provide further characterization of SL uptake through
the clathrin-independent pathway, we showed extensive
colocalization of BODIPY-LacCer with Rh-CtxB and of
Rh-CtxB with caveolin-1–GFP (Figs. 4 and 5). These exper-
iments suggest that (a) CtxB marks the caveolar compart-
ment in human skin fibroblasts, as shown previously in
other cell types (Parton, 1994), and (b) most of the intracel-
lular LacCer analogue was present in a caveolin-1–positive
compartment after 5 min of internalization. However, we
note that transfection of human skin fibroblasts with an
NH2-terminal GFP construct of caveolin-1 had no effect on
internalization of the SL analogues in the present study (data
not shown) although this construct blocked internalization
of SV-40 via the caveolar pathway in CV-1 cells (Pelkmans
et al., 2001). In contrast to the LacCer analogue, we found
partial overlap of SM with both Rh-CtxB and DiI-LDL in
colocalization studies (Fig. 5). This result fully supports our
conclusion that SM is endocytosed approximately equally by
both pathways.
Finally, we note that the initial pathways of internaliza-
tion for the SL analogues were the same in SLSD cells as in
normal fibroblasts, since the uptake of LacCer and globoside
analogues was nearly completely inhibited by m -CD in
both normal (Table I) and SLSD cells (Fig. 6 a), whereas
SM uptake was only partially inhibited by the different
classes of inhibitors (Table I; Fig. 6) or by expression of
dominant negative Eps15 (data not shown).
Initial mechanisms of SL internalization determine the 
utilization of two distinct Golgi targeting pathways
Our studies have further defined the pathways by which PM
SLs are internalized and transported to the Golgi apparatus
versus the late endosomes and lysosomes (Fig. 8). When
SLSD cells were pulse labeled with BODIPY-SM, the fluo-
rescent lipid entered cells by a combination of clathrin-
dependent and -independent internalization mechanisms.
These dual pathways of uptake gave rise to both punctate cy-
toplasmic labeling and to Golgi labeling as seen in Fig. 6 a.
The “Golgi component” of this fluorescence could be elimi-
nated by blocking uptake through the clathrin pathway
(e.g., by chlorpromazine treatment or by expression of dom-
inant negative Eps15), whereas the “punctate cytoplasmic”
component could be eliminated by inhibition of the clath-
rin-independent internalization (i.e., by m -CD treatment)
(Fig. 6 a, right versus middle panels for SM).
We showed previously that the Golgi complex targeting of
BODIPY-LacCer is disrupted in SLSD cells due to elevated
levels of intracellular cholesterol, and that a similar effect oc-
curs in normal fibroblasts overloaded with LDL-cholesterol
(Puri et al., 1999). Since LacCer is internalized almost exclu-
sively by clathrin-independent endocytosis, we conclude
that the intracellular Golgi complex targeting initiated by in-
Figure 8. Model for internalization 
and targeting of SLs in normal and SLSD 
fibroblasts. LacCer and globoside were 
internalized nearly exclusively by a 
clathrin-independent mechanism, 
whereas SM was endocytosed approxi-
mately equally well by clathrin-indepen-
dent and clathrin-dependent processes. 
SL internalization through the clathrin-
dependent pathway was blocked by 
expression of dominant negative (DN) 
constructs of Dyn2 or Eps15, or by 
potassium depletion or chlorpromazine 
treatments. SL internalization through 
the clathrin-independent pathway was 
blocked by expression of a dominant 
negative Dyn2 or by treatment of cells 
with m -CD, nystatin, or genistein. Lip-
ids initially internalized via clathrin-
dependent or -independent mecha-
nisms were subsequently transported to 
the lysosomes or Golgi apparatus. Only 
the pathway taken by SLs internalized 
by the clathrin-independent mechanism 
was modulated by cellular cholesterol. 
Thus, in normal fibroblasts, LacCer was 
targeted to the Golgi region, whereas in 
normal fibroblasts with excess choles-
terol (or in SLSD cells where cholesterol 
homeostasis is perturbed), the lipid was 
targeted to late endosomes and lyso-
somes. Lipids internalized by the two 
pathways may never intermix (solid black lines), or may intermix at some point along the endocytic pathway (dashed red lines) and then sub-
sequently segregate into discrete pathways which have different sensitivities to intracellular cholesterol.Endocytosis and targeting of sphingolipids | Puri et al. 545
ternalization through the clathrin-independent pathway is
modulated by intracellular cholesterol levels. The specificity
of this modulation by cholesterol was clearly demonstrated
by our studies of BODIPY-SM transport in SLSD cells and
in cholesterol-overloaded normal cells, where we showed
that the Golgi targeting of SM internalized by the clathrin-
independent mechanism was disrupted, whereas the Golgi
complex targeting of SM endocytosed via clathrin-coated
pits was unaffected (Fig. 6). In addition, control experi-
ments showed that the extent of endocytosis of LacCer and
SM by the clathrin-dependent versus clathrin-independent
mechanisms was not significantly altered in normal cells
grown in high concentrations of LDL (to elevate cellular
cholesterol) or in SLSD cells (data not shown). Therefore,
the changes in SL targeting induced by modulating intracel-
lular cholesterol levels were not due to effects on the initial
mode of internalization, but rather to specific cholesterol-
modulated alterations in the intracellular transport of lipids
at some point after clathrin-independent internalization.
Together, these results demonstrate that the initial path-
ways of SL internalization define two discrete Golgi target-
ing pathways as outlined in Fig. 8. We are currently further
characterizing these two pathways and have recently found
that SLs internalized by the clathrin-independent, caveolar-
like pathway reach a late endosomal compartment by a rab7-
dependent step before being transported to the Golgi appa-
ratus, whereas SLs internalized via the clathrin-mediated
pathway are targeted to the Golgi apparatus independent of
rab7 (unpublished data).
In summary, our studies provide convincing evidence for
the existence of two independent pathways for internaliza-
tion and Golgi targeting of PM SLs; however, many impor-
tant questions remain concerning these transport pathways.
(a) The mechanism for sorting of SL analogues into clathrin-
coated pits versus caveolar-like PM specializations is un-
known. Although we were able to observe differential sort-
ing and enrichment of LacCer and SM analogues in en-
docytic vesicles derived from different PM specializations
within the first 30–40 s of endocytosis (Fig. 2), we were un-
able to visualize a heterogeneous distribution of these ana-
logues at the PM before internalization (Fig. 1). The absence
of such heterogeneities, comparable in size to early endo-
somes, suggests that any PM “microdomains” were either
too small to be visualized (Kenworthy et al., 2000; Pralle et
al., 2000) by our current methods or an alternative mecha-
nism for sorting of PM SLs needs to be considered. (b) The
itinerary for the internalized SLs and the determinants for
Golgi complex targeting need to be identified. The dem-
onstration that only the targeting of SLs internalized via
the caveolar-like pathway was perturbed by cholesterol sug-
gests that SLs internalized by different mechanisms may be
transported through two different sets of endosomal com-
partments, only one of which is sensitive to intracellular
cholesterol. Further studies are required to define these
intracellular compartments and to determine the site and
mechanism by which cholesterol modulates targeting. The
existence of two endosomal pathways for Golgi complex tar-
geting of SLs also raises the question of where along the en-
dosomal pathway do components of vesicles derived from
the clathrin-dependent and -independent pathways intermix
(Tran et al., 1987) with one another. As depicted in Fig. 8,
it is possible that SLs internalized by the two pathways are
always in different endosomal vesicles and never intermix, or
alternatively intermix at some point along the endocytic
pathway, and then subsequently segregate into discrete path-
ways with unique characteristics with respect to cholesterol
modulation. (c) The functional significance of the two PM-
to-Golgi complex pathways needs to be determined. Pre-
sumably, the delivery of SLs to the Golgi complex by two in-
dependent routes represents part of the overall recycling
pathway for PM SLs. The possible internalization of LacCer
via caveolae and the modulation of LacCer targeting to the
Golgi complex by cellular cholesterol suggest a novel role for
sterol in regulating lipid recycling. These data also raise the
possibility that (some) cholesterol may be transported to the
Golgi complex (in normal cells) or retargeted to endosomes/
lysosomes (in SLSD cells) via the same pathway that we have
identified for the LacCer and globoside analogues.
Materials and methods
Cells and cell culture
Normal and SLSD skin fibroblasts were obtained from the Coriell Institute,
Human Genetic Mutant Cell Repository and cultured as described (Martin
and Pagano, 1994; Chen et al., 1999; Puri et al., 1999).
Fluorescent lipids, toxins, and other reagents
BODIPY-SM, BODIPY-Ceramide, and Lysotracker Red were from Molecu-
lar Probes. BODIPY-LacCer was synthesized and purified as described
(Martin and Pagano, 1994); BODIPY-globoside was synthesized in an
analogous manner using lyso-ceramide trihexoside (Matreya, Inc.). Com-
plexes of the BODIPY-SLs with defatted bovine serum albumin (DF-BSA)
were prepared as described (Martin and Pagano, 1994) and diluted in
HMEM (10 mM Hepes-buffered minimal essential medium, pH 7.4). Rh-
labeled CtxB was from List Biological Laboratories, Inc. FITC-labeled StxB
was a gift from Dr. David Haslam (Washington University School Medi-
cine, St. Louis, MO). DiI-LDL was from Intracel. All other reagents were
from Sigma-Aldrich unless otherwise noted.
Incubation of cells with BODIPY lipids
Cell cultures were washed with ice cold HMEM, transferred to a water
bath at 10 C, and then incubated with varying amounts of BODIPY-SL/DF-
BSA for 30 min to label the PM (see Results). The cells were then washed
with cold HMEM and warmed to 37 C for various times to induce endocy-
tosis. After this incubation, the medium was replaced with ice cold HMEM
without glucose containing the metabolic inhibitors, 5 mM NaN3, 50 mM
2-deoxyglucose, and 10  M CCCP (HMEM-G I), and the culture dishes
were transferred to a 10 C bath. Fluorescent lipid present at the cell sur-
face was then removed by “back exchange” (6   10 min incubations with
5% DF-BSA in HMEM-G I at 10 C [Chen et al., 1998]). The cells were
then observed under the fluorescence microscope using a temperature-
controlled stage maintained at 4 C.
Inhibitor treatments
Human skin fibroblasts grown on glass coverslips were treated with inhibi-
tors of endocytosis as follows. (a) Chlorpromazine (Gustavsson et al.,
1999; Okamoto et al., 2000): samples were incubated with 6  g/ml of the
drug for 30 min at 37 C and then pulse labeled with fluorescent lipid in the
presence of chlorpromazine. (b) Potassium depletion (Larkin et al., 1983;
Hansen et al., 1993): samples were rinsed with K
 -free buffer (140 mM
NaCl, 20 mM Hepes, 1 mM CaCl2, 1 mM MgCl2, 1 mg/ml D-glucose, pH
7.4) and then rinsed in hypotonic buffer (K
 -free buffer diluted 1:1 with
distilled water) for 5 min. Cells were then quickly washed three times in
K
 -free buffer and incubated for 20 min at 37 C in K
 -free buffer. Samples
were then incubated with fluorescent lipids as above, except that all solu-
tions were K
 -free. Control experiments were carried out in an identical
manner, except that all solutions contained 10 mM KCl. (c) m -CD
(Hansen et al., 2000; Okamoto et al., 2000): cells were pretreated with 10
mM m -CD in serum-free EMEM for 30 min at 37 C to deplete PM choles-
terol before incubation with fluorescent lipid. In separate experiments, cel-546 The Journal of Cell Biology | Volume 154, 2001
lular cholesterol was quantified (Slotte and Bierman, 1988) and found to
be   25% depleted by m -CD treatment. (d) Nystatin (Rothberg et al.,
1992): samples were incubated with 25  g/ml nystatin in serum-free
EMEM for 30 min at 37 C, washed with HMEM containing 25  g/ml nysta-
tin, and then pulse labeled with the fluorescent lipids in the presence of
nystatin. (e) Genistein (Aoki et al., 1999; Chen and Norkin, 1999; Liu and
Anderson, 1999): samples were pretreated with 200  M genistein for 2 h
in HMEM, washed, and pulse labeled with the fluorescent lipids as above
except with 200  M genistein present throughout. No significant differ-
ence in PM loading of the fluorescent SL analogues was observed in inhib-
itor-treated versus -untreated cells. For each inhibitor treatment, cell viabil-
ity was  90%; quantitative lipid analyses (Chen et al., 1998) also showed
that the degradation of the SM and LacCer analogues was  10%.
Transfection studies
The following GFP-constructs in mammalian expression vectors were gifts
as indicated: Eps15 (D3 2 [control] and the EH21 mutant E 95/295 [dom-
inant negative Eps15]) were from Drs. A. Benmerah and A. Dautry-Varsat
(Institut Pasteur, Paris, France); dynamin 2 (Dyn2ab [control] and GFP-
Dyn2ab K44A [dominant negative]) were from Dr. M. McNiven (Mayo
Clinic); NH2- and COOH-terminal GFP-constructs of caveolin-1 were from
Drs. L. Pelkmans and A. Helenius (Swiss Federal Institute of Technology)
and Dr. R.G.W. Anderson (University of Texas Southwestern, Dallas, TX).
Cells were treated with TransIT-LT1 transfection reagent (Mirus Corpora-
tion) and 2  g/ml DNA using the manufacturer’s protocol. After a 4–6-h
treatment, the cells were washed and subsequently cultured for 18–24 h in
EMEM containing 10% FBS before treatment with the fluorescent lipids as
above. Transfected cells were detected by GFP-fluorescence and the effect
on lipid internalization was evaluated from observations in the red region
of the spectrum where BODIPY-lipid, but not GFP-fluorescence, could be
visualized.
Microscopy and colocalization studies
Conventional fluorescence microscopy was performed with an fluores-
cence microscope (IX70; Olympus) equipped with filter packs which al-
lowed the specimens to be excited at 450–490 nm and viewed at “green”
( em   520-560 nm), “red” ( em   590 nm), or “green   red” ( em   520
nm) wavelengths (Pagano et al., 1991). Rh-CT and DiI-LDL–labeled speci-
mens were observed under the fluorescence microscope using optics ap-
propriate for these fluorophores ( ex   540/25 nm;  em   620/60 nm). In
any given experiment, all photomicrographs were exposed and printed
identically. Confocal microscopy was carried out using a ZEISS model 510
instrument using a 100  (1.4 NA) objective. Quantitative image analysis
was performed using the “Metamorph” image processing program (Univer-
sal Imaging Corp.) as described (Chen et al., 1997; Pagano et al., 2000).
For colocalization studies using BODIPY-SLs, cells were incubated for
30 min at 10 C with the BODIPY-lipid (see above) in the presence of 0.2
 M Rh-CtxB or 0.5  g/ml DiI-LDL (Molecular Probes, Inc.) and washed.
The samples were then incubated for 30 s at 37 C and back exchanged.
(For DiI-LDL treated specimens, the samples were then washed with
HMEM-G I and “acid stripped” to remove any DiI-LDL remaining at the
cell surface [Hopkins and Trowbridge, 1983]). Samples were then chased
at 37 C and observed under the fluorescence microscope. In control ex-
periments using cells in which only Rh-CtxB or DiI-LDL was present, no
fluorescence was detected with the “green” or “red” microscope filters un-
der the exposure conditions used for BODIPY-fluorescence.
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